- Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain Fox Business
- BioNTech says it will know vaccine's effectiveness against new variant in two weeks | TheHill The Hill
- Merck says its Covid antiviral treatment less effective than first thought Financial Times
- Pfizer and BioNTech investigating new Covid variant, as J&J tests vaccine against mutated virus CNBC
- With the Virus Still in Charge, Pfizer Can Be Flexible: Here's My Plan RealMoney
- View Full Coverage on Google News
from Top stories - Google News https://ift.tt/eA8V8J


0 Comments